<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48" class="ref">
 <label class="label">48.</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Priyanka</surname>
    <given-names class="given-names">A</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sindhu</surname>
    <given-names class="given-names">G</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shyni</surname>
    <given-names class="given-names">GL</given-names>
   </name>
   <name class="name">
    <surname class="surname">Preetha Rani</surname>
    <given-names class="given-names">MR</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nisha</surname>
    <given-names class="given-names">VM</given-names>
   </name>
   <name class="name">
    <surname class="surname">Raghu</surname>
    <given-names class="given-names">KG</given-names>
   </name>
  </person-group>. 
  <article-title class="article-title">Bilobalide abates inflammation, insulin resistance and secretion of angiogenic factors induced by hypoxia in 3T3-L1 adipocytes by controlling NF-κB and JNK activation</article-title>. 
  <source class="source">Int Immunopharmacol.</source> (
  <year class="year">2017</year>) 
  <volume class="volume">42</volume>:
  <fpage class="fpage">209</fpage>–
  <lpage class="lpage">17</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.intimp.2016.11.019</pub-id>
  <?supplied-pmid 27936435?>
  <pub-id pub-id-type="pmid" class="pub-id">27936435</pub-id>
 </mixed-citation>
</ref>
